Macquarie Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,241
| Closed | -$6K | – | 2498 |
|
|
2022
Q3 | $6K | Sell |
1,241
-2,731
| -69% | -$13.2K | ﹤0.01% | 2431 |
|
|
2022
Q2 | $8K | Hold |
3,972
| – | – | ﹤0.01% | 2484 |
|
|
2022
Q1 | $9 | Hold |
3,972
| – | – | ﹤0.01% | 2526 |
|
|
2021
Q4 | $18K | Hold |
3,972
| – | – | ﹤0.01% | 2426 |
|
|
2021
Q3 | $30K | Hold |
3,972
| – | – | ﹤0.01% | 2366 |
|
|
2021
Q2 | $38K | Hold |
3,972
| – | – | ﹤0.01% | 2221 |
|
|
2021
Q1 | $33K | Sell |
3,972
-621
| -14% | -$5.16K | ﹤0.01% | 2172 |
|
|
2020
Q4 | $31K | Hold |
4,593
| – | – | ﹤0.01% | 2146 |
|
|
2020
Q3 | $51K | Hold |
4,593
| – | – | ﹤0.01% | 1951 |
|
|
2020
Q2 | $29K | Buy |
+4,593
| New | +$29K | ﹤0.01% | 2069 |
|
|
2018
Q3 | – | Sell |
-3,300
| Closed | -$24K | – | 2317 |
|
|
2018
Q2 | $24K | Buy |
3,300
+1,600
| +94% | +$11.6K | ﹤0.01% | 2051 |
|
|
2018
Q1 | $9K | Buy |
+1,700
| New | +$9K | ﹤0.01% | 2127 |
|